LUpus Eritematoso Sistemico NETwork and Registry

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSocietà Italiana di Allergologia, Asma e Immunologia Clinica

About this trial

The LUNET Registry is intended to serve as a comprehensive primary data source, capturing real-world longitudinal clinical information, and the heterogeneity of patient presentations that are often underrepresented in traditional clinical trials. Ultimately, the LUNET Registry will help to optimize SLE management in routine clinical practice by enabling the compilation of real-world evidence to inform clinical decision-making and health policy. Patients will be enrolled by secondary and tertiary care centres for SLE across Italy in a real-world clinical set-up.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age ≥ 18 years;

confirmed SLE diagnosis according to the SLICC 2012 and/or ACR/EULAR 2019 classification criteria;

provision of signed written informed consent prior to participation

Disqualifiers

None

Trial population

Patients with SLE according to the SLICC 2012 and/or ACR/EULAR 2019 classification criteria

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Remission

Number of patients who achieved complete clinical remission or low disease activity

Time frame
Every year to ten year
2

Disease activity

Changes in disease activity (SLEDAI-2k)

Time frame
Every year to ten year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: